The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical research for rare disease: Opportunities, challenges, and solutions
Griggs, R. C., Batshaw, M., Dunkle, M., Gopal-Srivastava, R., Kaye, E., Krischer, J., Nguyen, T., Paulus, K., & Merkel, P. A. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.10.003 · Cited by 401 · cited 3×
“Increased focus on rare diseases over the last several decades has been spurred mainly by legislation intended to facilitate patient access to effective treatments by incentivizing pharmaceutical and biotechnology companies to develop new medicines that would otherwise not be profitable [1].”
BackgroundPłusa, T. (2012) · Journal of Health Policy & Outcomes Research · doi:10.7365/jhpor.2012.1.1 · Cited by 298
Rare diseases and orphan drugs
Melnikova, I. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3654 · Cited by 213
Adopting Orphan Drugs — Two Dozen Years of Treating Rare Diseases
Haffner, M. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmp058317 · Cited by 162
Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives
Song, P. (2012) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2012.v1.1.3 · Cited by 117
Rubinstein, Y., Groft, S. C., Bartek, R., Brown, K., Christensen, R., COLLIER, E. S., Farber, A., Farmer, J. M., Ferguson, J. H., Forrest, C. B., et al. (2010) · Contemporary Clinical Trials · doi:10.1016/j.cct.2010.06.007 · Cited by 111
Orphan Drugs for Rare Diseases
Simoens, S., Cassiman, D. M., Dooms, M. M., & Picavet, E. (2012) · Drugs · doi:10.2165/11635320-000000000-00000 · Cited by 74
Liu, B., He, L., He, G., & He, Y. (2010) · Journal of Public Health Policy · doi:10.1057/jphp.2010.30 · Cited by 38
Rare diseases and orphan drugs.
Taruscio, D., Capozzoli, F., & Frank, C. (2011) · PubMed · doi:10.4415/ann_11_01_17 · Cited by 38
Creating a European Union Framework for Actions in the Field of Rare Diseases
Moliner, A. M. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-9485-8_25 · Cited by 29
Research works printed but not linked: 2
- Badyal, 2006, Orphan diseases and drugs, Ind J Pharmacol, 38, 299, 10.4103/0253-7613.27036 · doi:10.4103/0253-7613.27036
- Montserrat Moliner, 2013, The European union policy in the field of rare diseases, Public Health Genomics, 16, 268, 10.1159/000355930 · doi:10.1159/000355930
Cited by
Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database
Nguengang Wakap, S., Lambert, D. M., Olry, A., Rodwell, C., Gueydan, C., Lanneau, V., Murphy, D., Le Cam, Y., & Rath, A. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-019-0508-0 · Cited by 1,752
Ferreira, C. R. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61124 · Cited by 498
Hegele, R. A., Borén, J., Ginsberg, H. N., Arca, M., Averna, M., Binder, C. J., Calabresi, L., Chapman, M. J., Cuchel, M., von Eckardstein, A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30264-5 · Cited by 204
Adachi, T., El-Hattab, A. W., Jain, R., Nogales Crespo, K. A., Quirland Lazo, C. I., Scarpa, M., Summar, M., & Wattanasirichaigoon, D. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20064732 · Cited by 168
“Such definitions are expressed as a fraction, a percentage, or the number of cases per population (whether that be from 10,000 or 100,000 people) [1].”
BackgroundEstablishing Patient Registries for Rare Diseases: Rationale and Challenges
Boulanger, V., Schlemmer, M., Rossov, S., Seebald, A., & Gavin, P. (2020) · Pharmaceutical Medicine · doi:10.1007/s40290-020-00332-1 · Cited by 124
Metadata
- Authors
- Richter, T., Nestler-Parr, S., Babela, R., Khan, Z. M., Tesoro, T., Molsen, E., & Hughes, D. A.
- Venue
- Value in Health
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 18
- Issue
- 6
- Pages
- 906-914
- ISSN
- 1098-3015 (ISSN-L)
- OpenAlex
- W2145695460
- Cited by
- 590
- References
- 10
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 366 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group. https://app.cochat.ai/papers/10.1016/j.jval.2015.05.008
- The paper
- Richter, T., Nestler-Parr, S., Babela, R., Khan, Z. M., Tesoro, T., Molsen, E., & Hughes, D. A. (2015). Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group. Value in Health. https://doi.org/10.1016/j.jval.2015.05.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.